Result of AGM

Summary by AI BETAClose X

Diaceutics PLC announced that all resolutions proposed at its Annual General Meeting on June 25, 2026, were duly passed by shareholders. The financial statements for the year ended December 31, 2025, were received with 99.99% of votes in favour. The directors' remuneration report was approved with 97.33% of votes for. Re-elections of directors Graham Paterson, Peter Keeling, Ryan Keeling, Nick Roberts, Jordan Clark, and Cheryl MacDiarmid all received substantial support, ranging from 86.38% to 99.22% of votes cast. Ernst & Young was re-appointed as auditors with 99.92% of votes in favour, and the directors were authorized to determine auditor remuneration and allot ordinary shares, with both resolutions passing with over 99.98% of votes. The company also received strong approval for its special resolution to dis-apply statutory pre-emption rights (99.96%) and to make market purchases of its ordinary shares (99.99%).

Disclaimer*

Companies

Diaceutics (DXRX)
UK 100

Latest directors dealings